| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.855 | 0.003 | 0.855 | DNA directed RNA polymerase inhibitor | 0.218 0.011 DBMET01864 0.233 0.01 DBMET01865 0.205 0.013 DBMET01867 0.225 0.011 DBMET01868 0.118 0.039 DBMET01870 0.169 0.019 DBMET01866 0.157 0.022 DBMET01869 | ||
| 0.738 | 0.005 | 0.738 | Tyrosine kinase inhibitor | 0.536 0.015 DBMET01864 0.594 0.011 DBMET01865 0.426 0.025 DBMET01867 0.639 0.009 DBMET01868 | ||
| 0.63 | 0.005 | 0.63 | Src kinase inhibitor | 0.56 0.005 DBMET01864 0.517 0.005 DBMET01865 0.439 0.009 DBMET01867 0.506 0.006 DBMET01868 0.165 0.074 DBMET01866 0.14 0.09 DBMET01869 | ||
| 0.563 | 0.004 | 0.563 | Lck kinase inhibitor | 0.512 0.005 DBMET01864 0.494 0.005 DBMET01865 0.448 0.005 DBMET01867 0.467 0.005 DBMET01868 0.122 0.084 DBMET01870 0.181 0.049 DBMET01866 0.144 0.069 DBMET01869 | ||
| 0.492 | 0.031 | 0.492 | Angiogenesis inhibitor | 0.482 0.033 DBMET01864 0.373 0.062 DBMET01865 0.355 0.069 DBMET01867 0.393 0.056 DBMET01868 0.191 0.18 DBMET01870 0.418 0.048 DBMET01866 0.419 0.048 DBMET01869 | ||
| 0.452 | 0.004 | 0.452 | HIV-1 reverse transcriptase inhibitor | 0.11 0.026 DBMET01864 0.121 0.021 DBMET01865 0.101 0.03 DBMET01867 0.116 0.023 DBMET01868 | ||
| 0.421 | 0.005 | 0.421 | Protein-tyrosine kinase Lyn inhibitor | 0.401 0.007 DBMET01864 0.37 0.009 DBMET01865 0.332 0.014 DBMET01867 0.337 0.014 DBMET01868 0.133 0.075 DBMET01870 | ||
| 0.439 | 0.069 | 0.439 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.395 0.105 DBMET01864 0.388 0.112 DBMET01865 0.293 0.223 DBMET01867 0.401 0.1 DBMET01868 | ||
| 0.356 | 0.011 | 0.356 | c-Src kinase inhibitor | 0.355 0.011 DBMET01864 0.327 0.014 DBMET01865 0.286 0.02 DBMET01867 0.335 0.013 DBMET01868 | ||
| 0.364 | 0.023 | 0.364 | Death-associated protein kinase 3 inhibitor | 0.319 0.033 DBMET01864 0.322 0.032 DBMET01865 0.26 0.049 DBMET01867 0.349 0.026 DBMET01868 | ||
| 0.342 | 0.008 | 0.342 | Protein kinase (CK2) alpha inhibitor | 0.136 0.051 DBMET01864 0.129 0.056 DBMET01865 0.093 0.084 DBMET01867 0.138 0.049 DBMET01868 | ||
| 0.353 | 0.022 | 0.353 | ErbB-1 antagonist | 0.33 0.026 DBMET01864 0.272 0.042 DBMET01865 0.29 0.036 DBMET01867 0.302 0.033 DBMET01868 | ||
| 0.338 | 0.009 | 0.338 | MAP kinase 9 inhibitor | 0.128 0.046 DBMET01864 0.13 0.045 DBMET01865 0.093 0.068 DBMET01867 0.163 0.033 DBMET01868 | ||
| 0.349 | 0.021 | 0.369 | MAP kinase kinase 2 inhibitor | 0.329 0.026 DBMET01864 0.351 0.02 DBMET01865 0.296 0.036 DBMET01867 0.369 0.017 DBMET01868 | DBMET01868 | |
| 0.351 | 0.032 | 0.368 | Antimitotic | 0.289 0.047 DBMET01864 0.331 0.037 DBMET01865 0.232 0.067 DBMET01867 0.368 0.029 DBMET01868 0.234 0.066 DBMET01866 0.239 0.064 DBMET01869 | DBMET01868 | |
| 0.338 | 0.022 | 0.363 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.357 0.019 DBMET01864 0.352 0.019 DBMET01865 0.322 0.025 DBMET01867 0.363 0.018 DBMET01868 0.163 0.115 DBMET01866 0.162 0.117 DBMET01869 | DBMET01868 | |
| 0.303 | 0.009 | 0.401 | Ephrin antagonist | 0.293 0.01 DBMET01864 0.381 0.005 DBMET01865 0.292 0.01 DBMET01867 0.401 0.005 DBMET01868 0.149 0.037 DBMET01866 0.162 0.034 DBMET01869 | DBMET01868 | |
| 0.281 | 0.011 | 0.281 | MAP kinase kinase inhibitor | 0.271 0.012 DBMET01864 0.209 0.026 DBMET01865 0.189 0.032 DBMET01867 0.208 0.026 DBMET01868 | ||
| 0.284 | 0.014 | 0.288 | Polo-like kinase-3 inhibitor | 0.264 0.02 DBMET01864 0.274 0.017 DBMET01865 0.237 0.029 DBMET01867 0.288 0.014 DBMET01868 | DBMET01868 | |
| 0.28 | 0.011 | 0.28 | CDK/cyclin complex inhibitor | 0.205 0.018 DBMET01864 0.204 0.018 DBMET01865 0.16 0.027 DBMET01867 0.258 0.013 DBMET01868 | ||
| 0.269 | 0.009 | 0.269 | MAP kinase 8 inhibitor | 0.166 0.024 DBMET01864 0.134 0.036 DBMET01865 0.106 0.054 DBMET01867 0.166 0.024 DBMET01868 | ||
| 0.265 | 0.01 | 0.265 | Protein kinase (CK2) inhibitor | 0.106 0.059 DBMET01864 0.106 0.058 DBMET01865 0.123 0.046 DBMET01868 | ||
| 0.26 | 0.005 | 0.26 | MAP3K7 inhibitor | 0.073 0.049 DBMET01864 0.081 0.039 DBMET01865 0.072 0.05 DBMET01867 0.091 0.028 DBMET01868 | ||
| 0.296 | 0.041 | 0.302 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.302 0.038 DBMET01864 0.281 0.046 DBMET01865 0.258 0.057 DBMET01867 0.285 0.044 DBMET01868 | DBMET01864 | |
| 0.268 | 0.015 | 0.268 | Cyclin-dependent kinase 1 inhibitor | 0.16 0.037 DBMET01864 0.168 0.034 DBMET01865 0.135 0.047 DBMET01867 0.216 0.024 DBMET01868 | ||
| 0.276 | 0.023 | 0.295 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.295 0.018 DBMET01864 0.224 0.035 DBMET01865 0.237 0.032 DBMET01867 0.218 0.037 DBMET01868 | DBMET01864 | |
| 0.256 | 0.007 | 0.256 | ALK inhibitor | 0.165 0.017 DBMET01864 0.156 0.018 DBMET01865 0.126 0.027 DBMET01867 0.177 0.014 DBMET01868 | ||
| 0.279 | 0.03 | 0.313 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.312 0.023 DBMET01864 0.285 0.029 DBMET01865 0.226 0.042 DBMET01867 0.313 0.023 DBMET01868 | DBMET01868 | |
| 0.256 | 0.009 | 0.256 | MAP kinase kinase kinase inhibitor | |||
| 0.27 | 0.024 | 0.27 | Protein kinase (CK1) gamma inhibitor | 0.187 0.049 DBMET01864 0.17 0.057 DBMET01865 0.126 0.084 DBMET01867 0.178 0.053 DBMET01868 | ||
| 0.269 | 0.024 | 0.269 | Cyclin-dependent kinase inhibitor | 0.173 0.046 DBMET01864 0.174 0.046 DBMET01865 0.133 0.065 DBMET01867 0.224 0.032 DBMET01868 | ||
| 0.275 | 0.031 | 0.292 | Growth factor antagonist | 0.292 0.028 DBMET01864 0.238 0.037 DBMET01865 0.18 0.053 DBMET01867 0.291 0.029 DBMET01868 | DBMET01864 | |
| 0.256 | 0.019 | 0.256 | Protein kinase (CK1) gamma 2 inhibitor | 0.165 0.043 DBMET01864 0.148 0.049 DBMET01865 0.11 0.073 DBMET01867 0.158 0.046 DBMET01868 | ||
| 0.248 | 0.015 | 0.248 | Epidermal growth factor receptor kinase inhibitor | 0.218 0.021 DBMET01864 0.207 0.023 DBMET01865 0.191 0.029 DBMET01867 0.235 0.018 DBMET01868 0.104 0.092 DBMET01866 0.108 0.086 DBMET01869 | ||
| 0.281 | 0.048 | 0.349 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.23 0.063 DBMET01864 0.313 0.039 DBMET01865 0.169 0.097 DBMET01867 0.349 0.028 DBMET01868 | DBMET01868 | |
| 0.235 | 0.004 | 0.235 | Protein kinase C theta inhibitor | 0.092 0.009 DBMET01864 0.098 0.008 DBMET01865 0.083 0.013 DBMET01867 0.105 0.007 DBMET01868 | ||
| 0.261 | 0.032 | 0.298 | I kappa B kinase epsilon inhibitor | 0.234 0.046 DBMET01864 0.275 0.025 DBMET01865 0.224 0.053 DBMET01867 0.298 0.016 DBMET01868 | DBMET01868 | |
| 0.243 | 0.022 | 0.243 | Cyclin-dependent kinase 7 inhibitor | 0.164 0.05 DBMET01864 0.175 0.045 DBMET01865 0.141 0.066 DBMET01867 0.188 0.039 DBMET01868 | ||
| 0.261 | 0.042 | 0.261 | CDC-like kinase 2 inhibitor | 0.18 0.078 DBMET01864 0.194 0.07 DBMET01865 0.13 0.109 DBMET01867 0.224 0.055 DBMET01868 | ||
| 0.229 | 0.01 | 0.229 | Insulin receptor antagonist | 0.167 0.023 DBMET01864 0.107 0.053 DBMET01865 0.086 0.083 DBMET01867 0.104 0.056 DBMET01868 | ||
| 0.225 | 0.014 | 0.225 | Aurora-C kinase inhibitor | 0.186 0.024 DBMET01864 0.195 0.021 DBMET01865 0.171 0.031 DBMET01867 0.211 0.017 DBMET01868 | ||
| 0.242 | 0.033 | 0.479 | RET inhibitor | 0.479 0.006 DBMET01864 0.221 0.038 DBMET01865 0.161 0.056 DBMET01867 0.24 0.033 DBMET01868 | DBMET01864 | |
| 0.212 | 0.007 | 0.212 | Protein kinase C delta inhibitor | 0.145 0.024 DBMET01864 0.159 0.018 DBMET01865 0.146 0.023 DBMET01867 0.169 0.014 DBMET01868 0.088 0.065 DBMET01866 0.101 0.051 DBMET01869 | ||
| 0.233 | 0.033 | 0.233 | Protein kinase (CK1) gamma 1 inhibitor | 0.205 0.041 DBMET01864 0.181 0.05 DBMET01865 0.146 0.072 DBMET01867 0.187 0.047 DBMET01868 | ||
| 0.246 | 0.05 | 0.246 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.138 0.105 DBMET01864 0.167 0.083 DBMET01865 0.127 0.117 DBMET01867 0.192 0.069 DBMET01868 | ||
| 0.268 | 0.075 | 0.268 | Transcription factor STAT inhibitor | |||
| 0.248 | 0.056 | 0.814 | Clk dual-specificity kinase inhibitor | 0.767 0.004 DBMET01864 0.759 0.004 DBMET01865 0.667 0.004 DBMET01867 0.814 0.004 DBMET01868 0.386 0.021 DBMET01870 0.412 0.017 DBMET01866 0.42 0.016 DBMET01869 | DBMET01868 | |
| 0.202 | 0.011 | 0.202 | Janus tyrosine kinase 2 inhibitor | 0.071 0.054 DBMET01865 0.091 0.041 DBMET01868 | ||
| 0.194 | 0.004 | 0.214 | ZAP-70 protein tyrosine kinase inhibitor | 0.189 0.004 DBMET01864 0.178 0.004 DBMET01865 0.134 0.005 DBMET01867 0.214 0.004 DBMET01868 0.072 0.045 DBMET01870 0.096 0.017 DBMET01866 0.096 0.017 DBMET01869 | DBMET01868 | |
| 0.212 | 0.023 | 0.235 | Aurora-A kinase inhibitor | 0.167 0.034 DBMET01864 0.2 0.025 DBMET01865 0.129 0.05 DBMET01867 0.235 0.019 DBMET01868 | DBMET01868 | |
| 0.238 | 0.05 | 0.238 | CDC-like kinase 4 inhibitor | 0.15 0.101 DBMET01864 0.157 0.095 DBMET01865 0.181 0.078 DBMET01868 | ||
| 0.192 | 0.005 | 0.192 | MAP kinase kinase 1 inhibitor | 0.182 0.007 DBMET01864 0.156 0.014 DBMET01865 0.138 0.022 DBMET01867 0.155 0.015 DBMET01868 | ||
| 0.203 | 0.017 | 0.203 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.18 0.032 DBMET01864 0.17 0.043 DBMET01865 0.162 0.053 DBMET01867 0.173 0.039 DBMET01868 | ||
| 0.197 | 0.012 | 0.197 | Janus tyrosine kinase 3 inhibitor | 0.072 0.05 DBMET01865 0.088 0.039 DBMET01868 | ||
| 0.226 | 0.051 | 0.23 | Focal adhesion kinase 2 inhibitor | 0.218 0.056 DBMET01864 0.229 0.049 DBMET01865 0.163 0.11 DBMET01867 0.23 0.048 DBMET01868 | DBMET01868 | |
| 0.204 | 0.031 | 0.204 | Death-associated protein kinase 2 inhibitor | 0.195 0.039 DBMET01864 0.167 0.072 DBMET01865 0.164 0.078 DBMET01867 0.17 0.069 DBMET01868 | ||
| 0.228 | 0.06 | 0.228 | MAP kinase kinase 3 inhibitor | 0.211 0.094 DBMET01864 0.217 0.08 DBMET01865 0.192 0.148 DBMET01867 0.223 0.068 DBMET01868 0.21 0.096 DBMET01870 | ||
| 0.324 | 0.156 | 0.324 | MAP kinase 1 inhibitor | |||
| 0.301 | 0.135 | 0.301 | MAP kinase kinase 6 inhibitor | |||
| 0.232 | 0.067 | 0.233 | EphB2 antagonist | 0.233 0.067 DBMET01864 0.192 0.093 DBMET01865 0.165 0.115 DBMET01867 0.164 0.116 DBMET01868 | DBMET01864 | |
| 0.175 | 0.011 | 0.175 | CDK1/cyclin B inhibitor | 0.12 0.019 DBMET01864 0.127 0.017 DBMET01865 0.1 0.024 DBMET01867 0.156 0.013 DBMET01868 | ||
| 0.258 | 0.099 | 0.27 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.243 0.113 DBMET01864 0.249 0.108 DBMET01865 0.225 0.131 DBMET01867 0.27 0.088 DBMET01868 | DBMET01868 | |
| 0.203 | 0.045 | 0.208 | Protein kinase (CK1) gamma 3 inhibitor | 0.208 0.042 DBMET01864 0.191 0.052 DBMET01865 0.165 0.074 DBMET01867 0.194 0.05 DBMET01868 | DBMET01864 | |
| 0.16 | 0.005 | 0.16 | Potassium channel (ATP-sensitive) blocker | 0.114 0.01 DBMET01864 0.13 0.007 DBMET01865 0.084 0.024 DBMET01867 0.099 0.016 DBMET01868 | ||
| 0.174 | 0.019 | 0.188 | CDK2/cyclin A inhibitor | 0.169 0.02 DBMET01864 0.17 0.02 DBMET01865 0.144 0.028 DBMET01867 0.188 0.016 DBMET01868 | DBMET01868 | |
| 0.167 | 0.012 | 0.167 | Polo-like kinase-1 inhibitor | 0.095 0.053 DBMET01864 0.146 0.018 DBMET01865 0.084 0.074 DBMET01867 0.159 0.014 DBMET01868 | ||
| 0.162 | 0.009 | 0.19 | CDK9/cyclin T1 inhibitor | 0.149 0.01 DBMET01864 0.162 0.009 DBMET01865 0.125 0.013 DBMET01867 0.19 0.007 DBMET01868 0.051 0.05 DBMET01869 | DBMET01868 | |
| 0.183 | 0.035 | 0.183 | Glycogen synthase kinase-3 inhibitor | 0.099 0.081 DBMET01868 | ||
| 0.192 | 0.046 | 0.192 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.159 0.066 DBMET01864 0.151 0.073 DBMET01865 0.129 0.095 DBMET01867 0.174 0.056 DBMET01868 | ||
| 0.16 | 0.014 | 0.16 | MAP kinase 10 inhibitor | |||
| 0.165 | 0.02 | 0.204 | Epidermal growth factor antagonist | 0.186 0.016 DBMET01864 0.17 0.019 DBMET01865 0.145 0.024 DBMET01867 0.204 0.014 DBMET01868 | DBMET01868 | |
| 0.161 | 0.016 | 0.161 | ErbB-3 antagonist | 0.125 0.027 DBMET01864 0.127 0.026 DBMET01865 0.105 0.037 DBMET01867 0.149 0.019 DBMET01868 | ||
| 0.173 | 0.035 | 0.173 | Glycogen synthase kinase-3 beta inhibitor | 0.093 0.087 DBMET01868 | ||
| 0.208 | 0.071 | 0.24 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.24 0.05 DBMET01864 0.222 0.061 DBMET01865 0.193 0.082 DBMET01867 0.234 0.054 DBMET01868 | DBMET01864 | |
| 0.152 | 0.016 | 0.177 | I kappa B kinase inhibitor | 0.098 0.04 DBMET01864 0.128 0.023 DBMET01865 0.089 0.049 DBMET01867 0.177 0.01 DBMET01868 | DBMET01868 | |
| 0.153 | 0.021 | 0.153 | Transcription factor STAT6 inhibitor | 0.103 0.098 DBMET01865 0.118 0.064 DBMET01868 | ||
| 0.152 | 0.02 | 0.152 | ErbB-4 antagonist | 0.1 0.04 DBMET01864 0.107 0.037 DBMET01865 0.076 0.055 DBMET01867 0.129 0.027 DBMET01868 | ||
| 0.179 | 0.049 | 0.179 | Cyclin-dependent kinase 3 inhibitor | 0.141 0.119 DBMET01864 0.156 0.083 DBMET01865 0.151 0.093 DBMET01867 0.171 0.059 DBMET01868 | ||
| 0.174 | 0.047 | 0.174 | Cytokine production inhibitor | 0.153 0.06 DBMET01865 0.137 0.073 DBMET01868 | ||
| 0.158 | 0.032 | 0.17 | Cyclin-dependent kinase 9 inhibitor | 0.128 0.042 DBMET01864 0.142 0.036 DBMET01865 0.102 0.06 DBMET01867 0.17 0.029 DBMET01868 | DBMET01868 | |
| 0.191 | 0.067 | 0.235 | LIM domain kinase 1 inhibitor | 0.204 0.061 DBMET01864 0.235 0.046 DBMET01865 0.163 0.086 DBMET01867 0.226 0.05 DBMET01868 | DBMET01865 | |
| 0.142 | 0.019 | 0.193 | Bcr-Abl kinase inhibitor | 0.167 0.014 DBMET01864 0.193 0.011 DBMET01865 0.146 0.018 DBMET01867 0.156 0.016 DBMET01868 | DBMET01865 | |
| 0.24 | 0.117 | 0.24 | Ca(v)3.3 blocker | |||
| 0.168 | 0.048 | 0.172 | Vascular endothelial growth factor antagonist | 0.172 0.047 DBMET01864 0.149 0.054 DBMET01865 0.097 0.085 DBMET01867 0.162 0.05 DBMET01868 | DBMET01864 | |
| 0.162 | 0.045 | 0.162 | Vascular endothelial growth factor 2 antagonist | 0.162 0.045 DBMET01864 0.141 0.052 DBMET01865 0.087 0.082 DBMET01867 0.153 0.048 DBMET01868 | ||
| 0.129 | 0.012 | 0.129 | T cell inhibitor | 0.106 0.02 DBMET01864 0.106 0.02 DBMET01865 0.097 0.028 DBMET01867 0.091 0.035 DBMET01868 0.093 0.033 DBMET01866 0.081 0.063 DBMET01869 | ||
| 0.164 | 0.048 | 0.195 | MAP kinase 3 inhibitor | 0.167 0.046 DBMET01864 0.195 0.026 DBMET01865 0.175 0.038 DBMET01867 0.195 0.026 DBMET01868 | DBMET01868 | |
| 0.13 | 0.014 | 0.13 | Focal adhesion kinase 1 inhibitor | 0.105 0.027 DBMET01864 0.112 0.022 DBMET01865 0.092 0.037 DBMET01867 0.12 0.018 DBMET01868 | ||
| 0.127 | 0.012 | 0.127 | Tyrosine-protein kinase EMT inhibitor | 0.05 0.046 DBMET01865 0.064 0.034 DBMET01868 | ||
| 0.133 | 0.02 | 0.133 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 0.126 0.023 DBMET01864 0.122 0.024 DBMET01865 0.107 0.032 DBMET01867 0.102 0.034 DBMET01868 0.086 0.045 DBMET01870 | ||
| 0.126 | 0.014 | 0.126 | MAP kinase kinase 10 inhibitor | 0.064 0.051 DBMET01865 0.068 0.043 DBMET01868 | ||
| 0.147 | 0.039 | 0.162 | Cyclin-dependent kinase 2 inhibitor | 0.131 0.046 DBMET01864 0.134 0.045 DBMET01865 0.106 0.063 DBMET01867 0.162 0.033 DBMET01868 | DBMET01868 | |
| 0.167 | 0.061 | 0.194 | Protein kinase C nu inhibitor | 0.15 0.069 DBMET01864 0.169 0.06 DBMET01865 0.124 0.089 DBMET01867 0.194 0.049 DBMET01868 | DBMET01868 | |
| 0.152 | 0.046 | 0.184 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | 0.176 0.035 DBMET01864 0.184 0.032 DBMET01865 0.158 0.044 DBMET01867 0.176 0.035 DBMET01868 | DBMET01865 | |
| 0.113 | 0.009 | 0.113 | Cyclin B1 inhibitor | 0.066 0.037 DBMET01864 0.066 0.036 DBMET01865 0.058 0.046 DBMET01867 0.07 0.032 DBMET01868 | ||
| 0.122 | 0.018 | 0.122 | Cyclin-dependent kinase 4 inhibitor | 0.099 0.026 DBMET01864 0.1 0.026 DBMET01865 0.076 0.037 DBMET01867 0.12 0.018 DBMET01868 | ||
| 0.162 | 0.058 | 0.162 | Glycogen synthase kinase-3 alpha inhibitor | 0.126 0.081 DBMET01864 0.135 0.076 DBMET01868 | ||
| 0.151 | 0.047 | 0.174 | Abl kinase inhibitor | 0.164 0.041 DBMET01864 0.174 0.036 DBMET01865 0.146 0.049 DBMET01867 0.166 0.04 DBMET01868 | DBMET01865 | |
| 0.2 | 0.099 | 0.687 | Dyrk kinase inhibitor | 0.619 0.005 DBMET01864 0.607 0.006 DBMET01865 0.546 0.01 DBMET01867 0.687 0.005 DBMET01868 0.239 0.077 DBMET01870 0.307 0.05 DBMET01866 0.333 0.041 DBMET01869 | DBMET01868 | |
| 0.175 | 0.075 | 0.369 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.171 0.077 DBMET01864 0.326 0.03 DBMET01865 0.126 0.11 DBMET01867 0.369 0.023 DBMET01868 | DBMET01868 | |
| 0.144 | 0.044 | 0.144 | Cyclin-dependent kinase 5 inhibitor | 0.094 0.081 DBMET01868 | ||
| 0.106 | 0.007 | 0.106 | Cyclin D3 inhibitor | 0.088 0.009 DBMET01864 0.094 0.008 DBMET01865 0.074 0.012 DBMET01867 0.1 0.007 DBMET01868 0.04 0.027 DBMET01866 0.039 0.028 DBMET01869 | ||
| 0.117 | 0.021 | 0.117 | Tyk2 inhibitor | |||
| 0.114 | 0.019 | 0.14 | CDK2/cyclin E inhibitor | 0.1 0.023 DBMET01864 0.111 0.019 DBMET01865 0.081 0.03 DBMET01867 0.14 0.014 DBMET01868 | DBMET01868 | |
| 0.121 | 0.027 | 0.141 | ErbB-2 antagonist | 0.13 0.024 DBMET01864 0.121 0.027 DBMET01865 0.103 0.034 DBMET01867 0.141 0.021 DBMET01868 | DBMET01868 | |
| 0.124 | 0.031 | 0.124 | Insulin growth factor antagonist | 0.117 0.036 DBMET01864 0.088 0.057 DBMET01865 0.094 0.051 DBMET01868 | ||
| 0.105 | 0.013 | 0.105 | CDK4/cyclin D inhibitor | 0.096 0.016 DBMET01864 0.088 0.018 DBMET01865 0.079 0.022 DBMET01867 0.104 0.013 DBMET01868 | ||
| 0.111 | 0.019 | 0.111 | Janus tyrosine kinase 1 inhibitor | |||
| 0.1 | 0.01 | 0.1 | Cyclin B inhibitor | 0.054 0.04 DBMET01864 0.054 0.039 DBMET01865 0.058 0.034 DBMET01868 | ||
| 0.115 | 0.028 | 0.115 | MAP-kinase-activated kinase inhibitor | |||
| 0.117 | 0.031 | 0.117 | Insulin like growth factor 1 antagonist | 0.104 0.039 DBMET01864 0.081 0.059 DBMET01865 0.086 0.053 DBMET01868 | ||
| 0.095 | 0.01 | 0.095 | Cyclin B2 inhibitor | 0.052 0.044 DBMET01864 0.054 0.041 DBMET01865 0.056 0.037 DBMET01868 | ||
| 0.186 | 0.102 | 0.678 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.607 0.005 DBMET01864 0.597 0.005 DBMET01865 0.539 0.009 DBMET01867 0.678 0.005 DBMET01868 0.253 0.066 DBMET01870 0.318 0.045 DBMET01866 0.346 0.036 DBMET01869 | DBMET01868 | |
| 0.092 | 0.011 | 0.092 | Cyclin H inhibitor | 0.08 0.019 DBMET01864 0.078 0.02 DBMET01865 0.071 0.027 DBMET01867 0.083 0.017 DBMET01868 | ||
| 0.12 | 0.039 | 0.12 | Breast cancer-resistant protein inhibitor | |||
| 0.095 | 0.016 | 0.097 | CDK4/cyclin D1 inhibitor | 0.087 0.02 DBMET01864 0.084 0.022 DBMET01865 0.076 0.027 DBMET01867 0.097 0.015 DBMET01868 | DBMET01868 | |
| 0.127 | 0.048 | 0.127 | Granulocyte macrophage colony stimulating factor antagonist | |||
| 0.093 | 0.017 | 0.142 | Bruton tyrosine kinase inhibitor | 0.065 0.029 DBMET01864 0.127 0.01 DBMET01865 0.088 0.018 DBMET01867 0.142 0.008 DBMET01868 | DBMET01868 | |
| 0.125 | 0.05 | 0.125 | EphA2 antagonist | 0.098 0.078 DBMET01864 0.106 0.069 DBMET01865 0.091 0.086 DBMET01867 0.108 0.067 DBMET01868 | ||
| 0.101 | 0.028 | 0.101 | MAP-kinase-activated kinase 2 inhibitor | |||
| 0.096 | 0.03 | 0.13 | CDK1/cyclin B1 inhibitor | 0.091 0.033 DBMET01864 0.099 0.029 DBMET01865 0.082 0.037 DBMET01867 0.13 0.02 DBMET01868 | DBMET01868 | |
| 0.073 | 0.01 | 0.073 | CDK7/cyclin H inhibitor | 0.06 0.015 DBMET01864 0.068 0.012 DBMET01865 0.059 0.016 DBMET01867 0.073 0.01 DBMET01868 | ||
| 0.139 | 0.076 | 0.169 | Activin receptor-like kinase 2 inhibitor | 0.128 0.087 DBMET01864 0.167 0.055 DBMET01865 0.125 0.091 DBMET01867 0.169 0.053 DBMET01868 | DBMET01868 | |
| 0.124 | 0.065 | 0.124 | Tyrosine-protein kinase receptor FLT3 inhibitor | |||
| 0.101 | 0.044 | 0.101 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.085 0.063 DBMET01868 | ||
| 0.072 | 0.016 | 0.077 | H+/K+-transporting ATPase inhibitor | 0.072 0.017 DBMET01864 0.077 0.014 DBMET01865 0.061 0.024 DBMET01867 0.057 0.028 DBMET01868 | DBMET01865 | |
| 0.131 | 0.076 | 0.185 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.147 0.066 DBMET01864 0.145 0.068 DBMET01865 0.185 0.05 DBMET01868 | DBMET01868 | |
| 0.059 | 0.005 | 0.059 | CDK6/cyclin D3 inhibitor | 0.043 0.01 DBMET01864 0.041 0.012 DBMET01865 0.038 0.016 DBMET01867 0.043 0.01 DBMET01868 | ||
| 0.098 | 0.044 | 0.098 | Leucine-rich repeat kinase 2 inhibitor | |||
| 0.109 | 0.057 | 0.109 | Platelet activating factor beta antagonist | 0.093 0.067 DBMET01864 0.094 0.067 DBMET01865 0.092 0.069 DBMET01868 | ||
| 0.116 | 0.065 | 0.117 | Interleukin 1b antagonist | 0.117 0.065 DBMET01865 0.102 0.079 DBMET01868 | DBMET01865 | |
| 0.083 | 0.032 | 0.083 | MAP kinase kinase 8 inhibitor | 0.063 0.058 DBMET01864 0.068 0.048 DBMET01865 0.078 0.036 DBMET01868 | ||
| 0.14 | 0.095 | 0.158 | CF transmembrane conductance regulator agonist | 0.138 0.099 DBMET01864 0.15 0.076 DBMET01865 0.148 0.079 DBMET01867 0.158 0.063 DBMET01868 0.133 0.112 DBMET01869 | DBMET01868 | |
| 0.078 | 0.037 | 0.078 | CDC7 inhibitor | |||
| 0.145 | 0.105 | 0.156 | TRKC antagonist | 0.138 0.113 DBMET01865 0.156 0.096 DBMET01868 | DBMET01868 | |
| 0.081 | 0.043 | 0.081 | Polo-like kinase-2 inhibitor | 0.063 0.061 DBMET01865 0.075 0.049 DBMET01868 | ||
| 0.11 | 0.072 | 0.131 | Aurora-B kinase inhibitor | 0.096 0.088 DBMET01864 0.12 0.065 DBMET01865 0.131 0.056 DBMET01868 | DBMET01868 | |
| 0.201 | 0.163 | 0.214 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.207 0.146 DBMET01865 0.214 0.129 DBMET01868 | DBMET01868 | |
| 0.055 | 0.018 | 0.055 | CDK5/p25 inhibitor | |||
| 0.114 | 0.078 | 0.114 | MAP kinase 12 inhibitor | 0.106 0.09 DBMET01864 0.103 0.093 DBMET01865 0.109 0.084 DBMET01868 | ||
| 0.067 | 0.032 | 0.167 | EphB4 antagonist | 0.068 0.031 DBMET01864 0.167 0.009 DBMET01865 0.085 0.021 DBMET01867 0.152 0.01 DBMET01868 | DBMET01865 | |
| 0.078 | 0.042 | 0.232 | Syk tyrosine kinase inhibitor | 0.118 0.021 DBMET01864 0.221 0.007 DBMET01865 0.119 0.021 DBMET01867 0.232 0.006 DBMET01868 | DBMET01868 | |
| 0.049 | 0.014 | 0.049 | Potassium channel Kv1.1 blocker | |||
| 0.125 | 0.09 | 0.716 | CDC-like kinase 1 inhibitor | 0.679 0.003 DBMET01864 0.666 0.003 DBMET01865 0.592 0.003 DBMET01867 0.716 0.003 DBMET01868 0.396 0.004 DBMET01870 0.403 0.004 DBMET01866 0.415 0.004 DBMET01869 | DBMET01868 | |
| 0.075 | 0.046 | 0.075 | Macrophage colony-stimulating factor 1 receptor antagonist | |||
| 0.271 | 0.244 | 0.648 | Antiinflammatory | 0.608 0.051 DBMET01866 0.648 0.041 DBMET01869 | DBMET01869 | |
| 0.082 | 0.055 | 0.082 | Platelet growth factor antagonist | |||
| 0.068 | 0.04 | 0.073 | Cyclin A2 inhibitor | 0.065 0.043 DBMET01865 0.073 0.037 DBMET01868 | DBMET01868 | |
| 0.13 | 0.103 | 0.13 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.071 | 0.047 | 0.108 | CDK2/cyclin E2 inhibitor | 0.083 0.037 DBMET01864 0.088 0.033 DBMET01865 0.07 0.048 DBMET01867 0.108 0.025 DBMET01868 | DBMET01868 | |
| 0.123 | 0.099 | 0.13 | CC chemokine 6 receptor antagonist | 0.13 0.069 DBMET01866 0.129 0.073 DBMET01869 | DBMET01866 | |
| 0.075 | 0.052 | 0.075 | MAP kinase 11 inhibitor | |||
| 0.062 | 0.04 | 0.062 | Heme oxygenase stimulant | |||
| 0.062 | 0.042 | 0.063 | Cyclin A inhibitor | 0.054 0.049 DBMET01865 0.063 0.042 DBMET01868 | DBMET01868 | |
| 0.169 | 0.15 | 0.186 | MAP-kinase-activated kinase 5 inhibitor | 0.186 0.122 DBMET01864 0.166 0.154 DBMET01868 | DBMET01864 | |
| 0.055 | 0.038 | 0.055 | Dihydroorotate oxidase inhibitor | |||
| 0.097 | 0.082 | 0.097 | Platelet activating factor antagonist | |||
| 0.086 | 0.073 | 0.086 | Platelet activating factor alpha antagonist | |||
| 0.085 | 0.078 | 0.093 | Vascular endothelial growth factor 1 antagonist | 0.085 0.078 DBMET01864 0.082 0.081 DBMET01865 0.093 0.07 DBMET01868 | DBMET01868 | |
| 0.054 | 0.048 | 0.054 | Cyclin-dependent kinase 6 inhibitor | |||
| 0.057 | 0.052 | 0.057 | Transcription factor AP-1 inhibitor | |||
| 0.027 | 0.023 | 0.027 | DNA polymerase III inhibitor | |||
| 0.045 | 0.042 | 0.045 | Potassium channel (Inward rectifier) blocker | |||
| 0.062 | 0.062 | 0.069 | I kappa B kinase 1 inhibitor | 0.069 0.05 DBMET01868 | DBMET01868 | |
| 0.058 | 0.065 | 0.07 | Protein kinase C alpha inhibitor | 0.07 0.043 DBMET01868 | DBMET01868 | |
| 0.054 | 0.066 | 0.072 | Cyclin B3 inhibitor | 0.07 0.046 DBMET01864 0.062 0.054 DBMET01865 0.072 0.044 DBMET01868 | DBMET01868 | |
| 0.09 | 0.104 | 0.413 | CDC-like kinase 3 inhibitor | 0.378 0.003 DBMET01864 0.356 0.003 DBMET01865 0.32 0.003 DBMET01867 0.413 0.003 DBMET01868 0.232 0.005 DBMET01870 0.22 0.005 DBMET01866 0.225 0.005 DBMET01869 | DBMET01868 | |
| 0.059 | 0.084 | 0.071 | Fibroblast growth factor 3 antagonist | 0.071 0.064 DBMET01864 0.07 0.065 DBMET01865 | DBMET01864 | |
| 0.028 | 0.076 | 0.039 | Thymidine kinase inhibitor | 0.037 0.036 DBMET01868 0.039 0.031 DBMET01870 | DBMET01870 | |
| 0.034 | 0.087 | 0.09 | Purinergic P2X2 antagonist | 0.09 0.035 DBMET01864 0.058 0.053 DBMET01865 0.072 0.044 DBMET01867 0.064 0.049 DBMET01868 0.079 0.04 DBMET01870 | DBMET01864 | |
| 0.13 | 0.193 | 0.173 | Growth factor agonist | 0.173 0.097 DBMET01865 0.152 0.138 DBMET01867 0.15 0.141 DBMET01868 | DBMET01865 | |
| 0.119 | 0.184 | 0.143 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.143 0.137 DBMET01868 | DBMET01868 | |
| 0.203 | 0.269 | 0.499 | Apoptosis agonist | 0.345 0.142 DBMET01864 0.243 0.222 DBMET01865 0.256 0.208 DBMET01867 0.249 0.215 DBMET01868 0.417 0.106 DBMET01870 0.477 0.082 DBMET01866 0.499 0.075 DBMET01869 | DBMET01869 | |
| 0.038 | 0.127 | 0.073 | I kappa B kinase 2 inhibitor | 0.073 0.029 DBMET01868 | DBMET01868 | |
| 0.066 | 0.158 | 0.151 | Toll-Like receptor 3 antagonist | 0.123 0.027 DBMET01864 0.138 0.019 DBMET01865 0.123 0.027 DBMET01867 0.151 0.014 DBMET01868 0.095 0.058 DBMET01866 0.093 0.062 DBMET01869 | DBMET01868 | |
| 0.062 | 0.155 | 0.236 | DNA polymerase I inhibitor | 0.102 0.084 DBMET01865 0.095 0.091 DBMET01867 0.113 0.074 DBMET01868 0.236 0.019 DBMET01870 0.156 0.046 DBMET01866 0.166 0.041 DBMET01869 | DBMET01870 | |
| 0.031 | 0.125 | 0.063 | Cyclin D1 inhibitor | 0.063 0.038 DBMET01868 | DBMET01868 | |
| 0.089 | 0.187 | 0.15 | MAP3K9 inhibitor | 0.136 0.082 DBMET01865 0.126 0.101 DBMET01867 0.15 0.06 DBMET01868 | DBMET01868 | |
| 0.019 | 0.121 | 0.032 | Glutamate (mGluR4) agonist | 0.032 0.027 DBMET01868 | DBMET01868 | |
| 0.007 | 0.116 | 0.016 | Adenosine A2b receptor agonist | 0.016 0.008 DBMET01870 | DBMET01870 | |
| 0.016 | 0.153 | 0.039 | Purinergic P2Y2 antagonist | 0.039 0.017 DBMET01870 | DBMET01870 | |
| 0.121 | 0.286 | 0.25 | RNA-directed DNA polymerase inhibitor | 0.171 0.15 DBMET01865 0.167 0.158 DBMET01868 0.25 0.049 DBMET01870 | DBMET01870 | |
| 0.049 | 0.243 | 0.145 | Transcription factor NF kappa B stimulant | 0.093 0.047 DBMET01865 0.087 0.056 DBMET01867 0.097 0.042 DBMET01868 0.104 0.035 DBMET01870 0.121 0.025 DBMET01866 0.145 0.017 DBMET01869 | DBMET01869 | |
| 0.055 | 0.252 | 0.122 | Interleukin 12 antagonist | 0.105 0.047 DBMET01864 0.122 0.027 DBMET01865 0.115 0.034 DBMET01867 0.12 0.029 DBMET01868 0.106 0.044 DBMET01866 0.111 0.038 DBMET01869 | DBMET01865 | |
| 0.051 | 0.25 | 0.171 | Carbonic anhydrase XV inhibitor | 0.1 0.067 DBMET01864 0.168 0.025 DBMET01865 0.132 0.039 DBMET01867 0.171 0.024 DBMET01868 | DBMET01868 | |
| 0.002 | 0.211 | 0.024 | Purinergic P2 agonist | 0.024 0.005 DBMET01870 | DBMET01870 | |
| 0.002 | 0.211 | 0.024 | Purinergic receptor agonist | 0.024 0.005 DBMET01870 | DBMET01870 | |
| 0.057 | 0.27 | 0.12 | Interleukin 4 antagonist | 0.11 0.1 DBMET01866 0.12 0.085 DBMET01869 | DBMET01869 | |
| 0.005 | 0.233 | 0.033 | Purinergic P2X agonist | 0.033 0.015 DBMET01870 | DBMET01870 | |
| 0.072 | 0.312 | 0.23 | Tumour necrosis factor alpha release inhibitor | 0.223 0.09 DBMET01866 0.23 0.086 DBMET01869 | DBMET01869 | |
| 0.067 | 0.313 | 0.163 | Platelet aggregation inhibitor | 0.163 0.114 DBMET01864 | DBMET01864 | |
| 0.005 | 0.251 | 0.036 | Adenosine A1 receptor agonist | 0.036 0.009 DBMET01870 | DBMET01870 | |
| 0.096 | 0.343 | 0.541 | Immunosuppressant | 0.456 0.045 DBMET01864 0.448 0.048 DBMET01865 0.43 0.053 DBMET01867 0.448 0.048 DBMET01868 0.435 0.052 DBMET01870 0.541 0.023 DBMET01866 0.541 0.023 DBMET01869 | DBMET01869 | |
| 0.031 | 0.285 | 0.088 | Carbonic anhydrase VI inhibitor | 0.076 0.062 DBMET01865 0.075 0.064 DBMET01867 0.088 0.048 DBMET01868 | DBMET01868 | |
| 0.06 | 0.316 | 0.23 | Nitric oxide antagonist | 0.205 0.065 DBMET01866 0.23 0.057 DBMET01869 | DBMET01869 | |
| 0.047 | 0.305 | 0.227 | Amyloid beta aggregation inhibitor | 0.227 0.065 DBMET01864 0.134 0.122 DBMET01866 0.145 0.112 DBMET01869 | DBMET01864 | |
| 0.002 | 0.266 | 0.018 | Purinergic P2Y agonist | 0.018 0.005 DBMET01870 | DBMET01870 | |
| 0.006 | 0.272 | 0.017 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.017 0.012 DBMET01866 0.017 0.01 DBMET01869 | DBMET01869 | |
| 0.031 | 0.32 | 0.094 | Protein kinase C gamma inhibitor | 0.094 0.089 DBMET01868 | DBMET01868 | |
| 0.059 | 0.36 | 0.345 | Hemostatic | 0.303 0.015 DBMET01866 0.345 0.012 DBMET01869 | DBMET01869 | |
| 0.102 | 0.413 | 0.352 | Peptidyltransferase inhibitor | 0.352 0.012 DBMET01870 0.313 0.02 DBMET01866 0.314 0.02 DBMET01869 | DBMET01870 | |
| 0.051 | 0.37 | 0.362 | Antiamyloidogenic | 0.187 0.109 DBMET01864 0.16 0.133 DBMET01865 0.186 0.11 DBMET01868 0.329 0.044 DBMET01866 0.362 0.036 DBMET01869 | DBMET01869 | |
| 0.072 | 0.394 | 0.115 | Papain-like protease (SARS coronavirus) inhibitor | 0.115 0.095 DBMET01864 | DBMET01864 | |
| 0.013 | 0.335 | 0.055 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.055 0.041 DBMET01870 | DBMET01870 | |
| 0.018 | 0.356 | 0.076 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.076 0.045 DBMET01870 | DBMET01870 | |
| 0.004 | 0.343 | 0.033 | Phosphoglycerate kinase inhibitor | 0.033 0.027 DBMET01870 | DBMET01870 | |
| 0.027 | 0.369 | 0.145 | Aminoacyl-tRNA synthetase inhibitor | 0.145 0.02 DBMET01870 | DBMET01870 | |
| 0.017 | 0.366 | 0.049 | Glucose-6-phosphate translocase inhibitor | 0.049 0.042 DBMET01869 | DBMET01869 | |
| 0.078 | 0.441 | 0.404 | Immunomodulator | 0.348 0.06 DBMET01866 0.404 0.043 DBMET01869 | DBMET01869 | |
| 0.062 | 0.427 | 0.358 | Transcription factor NF kappa B inhibitor | 0.272 0.112 DBMET01870 0.323 0.085 DBMET01866 0.358 0.074 DBMET01869 | DBMET01869 | |
| 0.044 | 0.409 | 0.258 | DNA methyltransferase I inhibitor | 0.258 0.044 DBMET01870 | DBMET01870 | |
| 0.036 | 0.411 | 0.142 | Cell adhesion inhibitor | 0.142 0.051 DBMET01866 0.123 0.063 DBMET01869 | DBMET01866 | |
| 0.044 | 0.429 | 0.287 | DNA methylase inhibitor | 0.287 0.032 DBMET01870 0.168 0.103 DBMET01866 0.171 0.1 DBMET01869 | DBMET01870 | |
| 0.018 | 0.431 | 0.069 | Purinergic P2X1 antagonist | 0.069 0.033 DBMET01870 | DBMET01870 | |
| 0.068 | 0.486 | 0.388 | Histamine release inhibitor | 0.358 0.096 DBMET01864 0.21 0.19 DBMET01865 0.302 0.123 DBMET01867 0.257 0.15 DBMET01868 0.388 0.082 DBMET01866 0.384 0.084 DBMET01869 | DBMET01866 | |
| 0.008 | 0.429 | 0.078 | Biliverdin reductase inhibitor | 0.078 0.027 DBMET01870 | DBMET01870 | |
| 0.021 | 0.445 | 0.074 | Glutamate dehydrogenase inhibitor | 0.074 0.052 DBMET01870 | DBMET01870 | |
| 0.057 | 0.496 | 0.245 | Cholesterol antagonist | 0.245 0.129 DBMET01869 | DBMET01869 | |
| 0.005 | 0.451 | 0.055 | Adenosine A1 receptor antagonist | 0.055 0.044 DBMET01870 | DBMET01870 | |
| 0.043 | 0.519 | 0.135 | NOS3 expression enhancer | 0.135 0.09 DBMET01866 0.129 0.1 DBMET01869 | DBMET01866 | |
| 0.006 | 0.488 | 0.087 | Phosphofructokinase-1 inhibitor | 0.087 0.037 DBMET01870 | DBMET01870 | |
| 0.016 | 0.503 | 0.047 | Alpha 1L adrenoreceptor agonist | 0.047 0.02 DBMET01864 | DBMET01864 | |
| 0.033 | 0.526 | 0.416 | DNA synthesis inhibitor | 0.193 0.134 DBMET01864 0.21 0.108 DBMET01865 0.205 0.116 DBMET01867 0.22 0.094 DBMET01868 0.416 0.02 DBMET01870 0.283 0.05 DBMET01866 0.33 0.035 DBMET01869 | DBMET01870 | |
| 0.016 | 0.515 | 0.048 | Factor IXa inhibitor | 0.048 0.04 DBMET01866 0.047 0.042 DBMET01869 | DBMET01866 | |
| 0.024 | 0.53 | 0.094 | NADH dehydrogenase inhibitor | 0.086 0.063 DBMET01870 0.08 0.074 DBMET01866 0.094 0.051 DBMET01869 | DBMET01869 | |
| 0.003 | 0.51 | 0.048 | Antimetabolite | 0.048 0.033 DBMET01870 | DBMET01870 | |
| 0.006 | 0.515 | 0.058 | Argininosuccinate synthase inhibitor | 0.058 0.038 DBMET01870 | DBMET01870 | |
| 0.006 | 0.539 | 0.272 | Selectin antagonist | 0.248 0.008 DBMET01866 0.272 0.007 DBMET01869 | DBMET01869 | |
| 0.016 | 0.606 | 0.346 | Free radical scavenger | 0.332 0.043 DBMET01866 0.346 0.04 DBMET01869 | DBMET01869 | |
| 0.021 | 0.618 | 0.394 | Antioxidant | 0.16 0.153 DBMET01867 0.162 0.151 DBMET01870 0.367 0.042 DBMET01866 0.394 0.036 DBMET01869 | DBMET01869 | |
| 0.004 | 0.611 | 0.017 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.017 0.009 DBMET01870 | DBMET01870 | |
| 0.026 | 0.636 | 0.153 | Cyclic AMP phosphodiesterase inhibitor | 0.153 0.148 DBMET01870 | DBMET01870 | |
| 0.049 | 0.665 | 0.227 | Caspase 3 stimulant | 0.195 0.176 DBMET01866 0.227 0.135 DBMET01869 | DBMET01869 | |
| 0.012 | 0.646 | 0.118 | M18 aspartyl aminopeptidase inhibitor | 0.118 0.072 DBMET01864 | DBMET01864 | |
| 0.009 | 0.67 | 0.071 | Topoisomerase II alpha inhibitor | 0.071 0.061 DBMET01869 | DBMET01869 | |
| 0.01 | 0.671 | 0.174 | Lipid peroxidase inhibitor | 0.154 0.065 DBMET01864 0.163 0.06 DBMET01867 0.171 0.055 DBMET01866 0.174 0.053 DBMET01869 | DBMET01869 | |
| 0.033 | 0.711 | 0.528 | Cyclophilin D inhibitor | 0.485 0.055 DBMET01866 0.528 0.043 DBMET01869 | DBMET01869 | |
| 0.017 | 0.7 | 0.062 | Adenine nucleotide translocase inhibitor | 0.052 0.049 DBMET01864 0.055 0.039 DBMET01867 0.061 0.026 DBMET01870 0.062 0.025 DBMET01866 0.057 0.034 DBMET01869 | DBMET01866 | |
| 0.011 | 0.696 | 0.336 | Immunostimulant | 0.272 0.088 DBMET01866 0.336 0.068 DBMET01869 | DBMET01869 | |
| 0.076 | 0.772 | 0.335 | Calcium channel L-type activator | 0.324 0.137 DBMET01865 0.335 0.129 DBMET01867 | DBMET01867 | |
| 0.014 | 0.72 | 0.159 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.159 0.128 DBMET01870 | DBMET01870 | |
| 0.004 | 0.728 | 0.019 | Adenosine A3 receptor agonist | 0.019 0.01 DBMET01870 | DBMET01870 | |
| 0.01 | 0.8 | 0.475 | Angiogenesis stimulant | 0.281 0.057 DBMET01870 0.439 0.016 DBMET01866 0.475 0.013 DBMET01869 | DBMET01869 | |
| 0.007 | 0.852 | 0.198 | Thrombolytic | 0.187 0.058 DBMET01866 0.198 0.053 DBMET01869 | DBMET01869 | |
| 0.018 | 0.864 | 0.286 | Hepatoprotectant | 0.151 0.109 DBMET01870 0.257 0.041 DBMET01866 0.286 0.034 DBMET01869 | DBMET01869 | |
| 0.006 | 0.853 | 0.553 | Antibacterial | 0.493 0.043 DBMET01870 0.52 0.035 DBMET01866 0.553 0.028 DBMET01869 | DBMET01869 | |
| 0.018 | 0.868 | 0.213 | Interleukin agonist | 0.213 0.109 DBMET01869 | DBMET01869 | |
| 0.013 | 0.871 | 0.14 | Toll-Like receptor 4 antagonist | 0.135 0.03 DBMET01866 0.14 0.027 DBMET01869 | DBMET01869 | |
| 0.003 | 0.879 | 0.079 | Antineoplastic antibiotic | 0.071 0.064 DBMET01866 0.079 0.058 DBMET01869 | DBMET01869 | |
| 0.018 | 0.908 | 0.312 | Apoptosis antagonist | 0.277 0.102 DBMET01866 0.312 0.078 DBMET01869 | DBMET01869 | |
| 0.005 | 0.897 | 0.289 | Antithrombotic | 0.241 0.133 DBMET01870 0.223 0.151 DBMET01866 0.289 0.095 DBMET01869 | DBMET01869 | |
| 0.008 | 0.928 | 0.419 | Hypoglycemic | 0.393 0.029 DBMET01866 0.419 0.025 DBMET01869 | DBMET01869 | |
| 0.03 | 0.961 | 0.477 | Interleukin 2 agonist | 0.267 0.101 DBMET01865 0.267 0.101 DBMET01867 0.279 0.09 DBMET01868 0.257 0.111 DBMET01870 0.44 0.017 DBMET01866 0.477 0.011 DBMET01869 | DBMET01869 | |
| 0.004 | 0.944 | 0.107 | Topoisomerase II inhibitor | 0.107 0.08 DBMET01869 | DBMET01869 | |
| 0.004 | 0.946 | 0.055 | Antibiotic Aminoglycoside-like | 0.051 0.012 DBMET01866 0.055 0.011 DBMET01869 | DBMET01869 | |
| 0.004 | 0.948 | 0.065 | Protein 50S ribosomal subunit inhibitor | 0.065 0.027 DBMET01866 0.065 0.027 DBMET01869 | DBMET01869 | |
| 0.02 | 0.968 | 0.136 | Lipocortins synthesis antagonist | 0.136 0.128 DBMET01870 | DBMET01870 | |
| 0.004 | 0.958 | 0.182 | Platelet antagonist | 0.182 0.115 DBMET01870 | DBMET01870 | |
| 0.006 | 0.962 | 0.27 | Platelet adhesion inhibitor | 0.21 0.066 DBMET01870 0.244 0.051 DBMET01866 0.27 0.043 DBMET01869 | DBMET01869 | |
| 0.003 | 0.977 | 0.133 | Topoisomerase I inhibitor | 0.133 0.048 DBMET01870 0.089 0.081 DBMET01866 0.129 0.051 DBMET01869 | DBMET01870 | |
| 0.001 | 0.995 | 0.022 | Protein 30S ribosomal subunit inhibitor | 0.022 0.019 DBMET01869 | DBMET01869 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |